Matthew Ros
2020
In 2020, Matthew Ros earned a total compensation of $1.6M as Executive Vice President, Chief Strategy and Business Officer at Epizyme, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $174,800 |
|---|---|
| Option Awards | $750,730 |
| Salary | $447,982 |
| Stock Awards | $250,006 |
| Other | $11,271 |
| Total | $1,634,789 |
Ros received $750.7K in option awards, accounting for 46% of the total pay in 2020.
Ros also received $174.8K in non-equity incentive plan, $448K in salary, $250K in stock awards and $11.3K in other compensation.
Rankings
In 2020, Matthew Ros' compensation ranked 6,462nd out of 13,090 executives tracked by ExecPay. In other words, Ros earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,462 out of 13,090 | 51st |
Division Manufacturing | 2,661 out of 5,618 | 53rd |
Major group Chemicals And Allied Products | 1,074 out of 2,251 | 52nd |
Industry group Drugs | 928 out of 1,951 | 52nd |
Industry Pharmaceutical Preparations | 694 out of 1,456 | 52nd |
Pay ratio
| Matthew Ros' Pay | $1,634,789 |
|---|---|
| Median Employee's Pay | $333,249 |
| Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Matthew Ros was $1,634,789.
The annual total compensation of the median employee at Epizyme was $333,249.
The ratio of Matthew Ros' pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 29, 2021.
Ros' colleagues
We found four more compensation records of executives who worked with Matthew Ros at Epizyme in 2020.